key: cord-0330995-ftvx3ega
authors: Tamanaha, Esta; Zhang, Yinhua; Tanner, Nathan A.
title: Profiling RT-LAMP tolerance of sequence variation for SARS-CoV-2 RNA detection
date: 2021-10-25
journal: bioRxiv
DOI: 10.1101/2021.10.25.465706
sha: ebe0e7d981427f2228d52e24dac8b137565c3afc
doc_id: 330995
cord_uid: ftvx3ega

The ongoing SARS-CoV-2 pandemic has necessitated a dramatic increase in our ability to conduct molecular diagnostic tests, as accurate detection of the virus is critical in preventing its spread. However, SARS-CoV-2 variants continue to emerge, with each new variant potentially affecting widely-used nucleic acid amplification diagnostic tests. RT-LAMP has emerged as a quick, inexpensive diagnostic alternative to RT-qPCR, but has not been studied as thoroughly. Here we interrogate the effect of SARS-CoV-2 sequence mutations on RT-LAMP amplification, creating 572 single point mutation “variants” covering every position of the LAMP primers in 3 SARS-CoV-2 assays and analyzing their effects with over 4,500 RT-LAMP reactions. Remarkably, we observed only minimal effects on amplification speed and no effect on detection sensitivity, highlighting RT-LAMP as an extremely robust technique for viral RNA detection. Additionally, we describe the use of molecular beacons to sensitively identify variant RNA sequences. Together these data add to the growing body of knowledge on the utility of RT-LAMP and increase its potential to further our ability to conduct molecular diagnostic tests outside of the traditional clinical laboratory environment.

Molecular diagnostic techniques are able to provide definitive identification of infectious agents through specific detection of DNA or RNA sequences of interest.

However, target pathogens, and particularly RNA viruses, naturally display mutations and changes in their genomic sequences that can impact the sensitivity and accuracy of the molecular diagnostic test when the mutations occur in the regions targeted by the oligonucleotide primers and/or probes. The ongoing SARS-CoV-2 pandemic has seen the emergence of numerous viral variants from different regions of the world, with prominent effects on detection using molecular assays. For example, the B.1.1.7 "alpha" variant features a 6-base deletion (removing 2 amino acids of the spike protein, Δ69-70) which causes a failure of the S Gene assay in the widely used TaqPath® COVID-19 multiplex RT-qPCR test (1) . The other targets in this assay are unaffected, resulting in the ability to provide preliminary identification of variant RNA during detection, identifying a sample for further sequencing analysis and variant determination. In this particular case the other targets can be used for diagnostic detection, but the sensitivity of RT-qPCR to variant mutations is a significant concern to diagnostic testing given the worldwide reliance on the method. Early in 2021 the FDA issued guidance to molecular test developers (2) calling for evaluation of variant sequences in development of any molecular test, emphasizing the significance of understanding assay performance in the presence of targeted region mutations.

While much is known about the effects of mutations in qPCR assays (3, 4) , loopmediated isothermal amplification (LAMP) diagnostic assays are much more recent technology and accordingly we have comparatively little information on mutation effects. 4 LAMP assays have been designed specifically to target SNPs in a sequence by placing the mutation directly at the 3′ or 5′ terminal base of both the FIP and BIP primers (5) , but this is a highly artificial scenario. Natural mutations would most frequently consist of single base changes along a priming region of the LAMP primers, or more rarely, multibase deletions. For example, the B.1.1.7 Alpha variant contains the 6-base SGTF Δ69-70 and 9-base Orf1a SGF 3675-3677 deletions, but also >18 characteristic single base change mutations, whereas the B.1.617.2 Delta variant contains >20 point mutations and 2 deletions different from those in Alpha (6) . In this study, we consider the 18 oligonucleotides making up 3 SARS-CoV-2 RT-LAMP assays. Mapping the primers onto SARS-CoV-2 sequences from GISAID shows numerous locations of mutation in small numbers of isolates worldwide, but a few (see 4 described in Methods) at a significant prevalence >10% of sequences deposited from at least 2 geographic locations independent from any of the well-known variants of interest or concern. Larger deletions likely have more detrimental effects on amplification than single base changes, though single base changes located close to the 3′ ends of primers might impact more than those located near the 5′ ends. Understanding the effects of singlebase mutations on the effect of an amplification assay is critical to monitoring its continued ability to detect the target of interest as that target may naturally change over time.

In addition to reliable and consistent detection of the target, there is additional value in assays that can specifically identify variants of concern. Sequencing of positive samples will remain the most powerful and sensitive method for variant identification, but molecular diagnostic assays can present a significantly faster and cheaper 5 approach if appropriately designed. The widely-used TaqMan probes rely on specific hybridization to targeted sequences and may display greater sensitivity to mutations than when they occur in primer regions; the Δ69-70 deletion occurs in the TaqPath probe region and completely prevents detection of RNA with that deletion. The SARS-CoV-2 variant strains B.1.1.7 (alpha), B.1.351 (beta), P.1 (gamma), B.1.617.2 (delta) and C.37 (lambda) contain numerous and distinctive mutations, most prominently located in the spike protein (1) . While only Alpha carries the Δ69-70 deletion, all but Delta carry a 9-base deletion at positions 3675-3677 in the Orf1a sequence (termed the "SGF" deletion). This relatively large deletion provides a reliable means for designing molecular diagnostic assays that can distinguish between strains differing at this sequence location (1).

RT-LAMP has played a role in point-of-care and fieldable diagnostics, but during the SARS-CoV-2 pandemic has emerged as a prominent and widely-used molecular diagnostic method (7) . Isothermal amplification can be performed with much simpler instrumentation that PCR, and detection of RT-LAMP can be conducted directly by visual color change (8, 9) , fluorescence (10), sequence-specific probe such as DARQ (11) and molecular beacons (12) , or coupled to secondary molecular analysis platforms such as CRISPR (13, 14) and next generation sequencing (e.g. LamPORE and LAMP-Seq) (15, 16) . Several SARS-CoV-2 diagnostic protocols based on RT-LAMP are currently being used for large-scale test (13, 14, 17, 18) and can utilize crude or unpurified samples, saving time and cost while increasing testing flexibility and portability, exemplified by the utilization of RT-LAMP in the first molecular diagnostic for at-home use granted EUA in November 2020 (18). 6 As with qPCR, LAMP relies on oligonucleotide primers and mutations in the targeted regions may affect amplification efficiency. However, there is significantly more complexity in LAMP, as it utilizes 6 primers derived from 8 regions in the target sequence, with each of these regions similar in length to a PCR primer (19, 20) . These 6 primers perform different roles during the amplification: F3 and B3 are located outside of the targeted region to aid in release of initial amplicons via strand displacement and are not incorporated into the amplification products. FIP and BIP are composed of two distinct target sequences and are the core primers responsible for the generation of the LAMP hairpin "dumbbell structure" and subsequent exponential amplification. LoopF and LoopB initiate from regions formed by "looping" from FIP and BIP and serve to further increase the speed of amplification.

And while previous studies of LAMP for SNP detection have described placing the mutation at the 3′ or 5′ terminus of both the FIP and BIP primers, this is very difficult to design in practice (5) . A more general understanding of the impact of mutations on the 6 LAMP primers has not been characterized in detail. We set out to systematically investigate the effect of mutations by introducing single base changes at every position of each LAMP primer in 3 commonly used SARS-CoV-2 LAMP assays and running RT-LAMP with different concentrations of SARS-CoV-2 RNA to analyze the effects on assay speed and sensitivity. As RT-LAMP becomes a more widely-used method these results help us to assess the influence of mutations that may fall in the various primer regions.

In order to provide solutions for distinguishing sequence variants rather than just tolerating them, we also designed a variant-specific LAMP detection method based on 7 molecular beacons. The use of molecular beacons containing locked nucleic acid has been previously demonstrated with LAMP (21, 22) and for SARS-CoV-2 detection (12) with beacons targeting the Gene S Δ69-70 deletion in the B.1.1.7 alpha variant (23).

Here we designed new molecular beacons targeting the 9-base SGF deletion in Orf1a, enabling identification of multiple variants of concern including B.1.1.7, B.1.351, and P.1.

Single point mutation LAMP primers: Three previously described SARS-CoV-2 LAMP primer sets for SARS-CoV-2 were chosen to profile mutational position effects: As1e (24), E1, and N2 (9) ( Table 1) . Point mutations were identified in GISAID sequences as monitored by NEB Primer Monitor (primer-montor.neb.com), and 4 mutations reported in >10% of deposited sequences from >1 reporting location were chosen for LAMP screening. These mutations were: C2395T, in the As1e BIP primer;

G2416T, in the As1e LoopB primer; T29148C, in the N2 F3 primer; and G29179T, in the N2 LoopF primer (locations seen noted in Table 1 targeting either wild-type or the SGF deletion sequence were designed using principles according to (12) . As the deletion is located in a relatively AT-rich region, the annealing temperatures for these beacons are lower: the calculated Tm of the annealed beacontarget for wt MB and SGFdel MB is 63.9 and 62.5 °C, and the stem is 55.1 and 54.7 °C, respectively. These beacons were synthesized as Affinity Plus qPCR Probes by IDT with sequences shown in Table 1 . 

To mimic the effect of a potential SARS-CoV-2 variant in an RT-LAMP assay, we focused on single point mutations at each primer base position and the SGF deletion that is found in several variants of concern. For the single point mutation primers, each of the 527 variant primers from the 3 assays (As1e, N2, E1) was tested in RT-LAMP 11 reactions with three different SARS-CoV-2 RNA copy number concentrations: 100, 200, and 10,000 copies in order to gain a sense of the mutation effect on reaction speed and sensitivity. Both lower concentrations allowed for amplification effects to be confidently determined outside of stochastic performance when close to the limit of detection (LOD ~50 copies) in the 100 copy reactions, particularly for the As1e primer set which displays slightly lower sensitivity in our testing. The reaction output speed was measured relative to the fully-complementary wild-type primer and plotted against the position in the primer sequence ( Figure 2) . Overall, the ~4,500 RT-LAMP assays containing single point mutations within any of the six primers resulted in minimal to no effect on the ability to amplify the target at any of the copy numbers used, regardless of primer and gene target. The most common result observed was a 5-10% reduction in amplification speed in the presence of a mismatch. the F3 primer did see some slowing when mismatches were present away from the 5′ end in the E1 and As1e sets ( Fig. 2A, B) . These primers are the least critical to the reaction, but the difference between the two may indicate differential mismatch indicating an impact on polymerase extension from a mismatch in the looped-back LAMP hairpin structure, but detection sensitivity was not impacted even with those primer sets. Surprisingly the speed of the N2 assay increased when mutations were present at internal and 3′ positions of the LoopF primer. This was not a consistent effect, and while difficult to anticipate from sequence prediction its underlying mechanism will be investigated further in future LAMP assays. As a summary of the effects Table 2 lists the number of positions from each primer that resulted in a change of more than 10% in time to detection from the WT primer baseline. Though overall effects on amplification were minimal, the greater impact of 3′ mutations is clear from the trends in Figure 2 .

And while a significant number of variant primers resulted in decreased reaction speeds, in all 527 variant primers tested no mutation position prevented amplification in the RT-LAMP reaction with SARS-CoV-2 RNA even with lower RNA copy numbers. 

To investigate the effect of a deletion on an RT-LAMP assay, we designed a primer set targeting the SGF deletion region (Orf1a 3675-3677) with two molecular beacons targeting either the WT or the variant target region (Fig. 1) . We initially evaluated this primer set for specificity and sensitivity and found it was able to detect both WT and variant RNAs with similar sensitivity of approximately 50 copies and with no apparent non-template amplification signal in 40 minute reactions (data not shown). We then evaluated detection using the molecular beacons with 10-fold dilutions of WT or B.1.1.7

synthetic RNA and compared them with conventional intercalating fluorescence detection. Both molecular beacons detected their intended targets as designed with 14 robust specificity and even at 10,000 copies of target RNA they recognized only their intended amplification products (Fig. 3) . This is in contrast to another strategy where the deletion was placed at the ends of the FIP and BIP (5) and detected with an intercalating dye. With this design, WT vs. B.1.1.7 discrimination was efficient at low (≤1,000 copies RNA) inputs but at higher copy numbers, the two variant sequences could only be distinguished by their amplification speed. (Table 3) . We further tested combining both molecular beacons in the same LAMP reaction for identification of the input viral RNA could be determined by running 24 repeat reactions in the presence of both SGFwt and SGFdel molecular beacons.

Results from these reactions showed that target RNAs were reliably detected with the same level of sensitivity when both beacons were present, and we observed no interference between the two beacons (Table 4) . where a 3′ mismatch causes a >100-fold sensitivity effect and can be used to completely discriminate a SNP due to inefficient mismatch extension (3). The robustness of RT-LAMP to sequence variation is a significant benefit over RT-qPCR, with reduced worry about deleterious effects from the commonly emerging single-base changes that could occur with some frequency in the regions targeted by the LAMP primers. Additionally, many RT-LAMP assays combine primer sets for added speed and sensitivity (9) , adding an additional layer of protection against possible sequence variation.

The converse of this assay robustness however is an inherent difficulty in identifying variants during the amplification reaction. While sequencing offers greater confidence and detail for variant calling the ability to utilize the diagnostic amplification for prospective variant identification as with the TaqPath S-gene dropout can be a valuable feature of a potential diagnostic method. We observed difficulty targeting even a large 9-base deletions by typical LAMP primer design alone, but by utilizing a molecular beacon approach as first described by (23) we were able to accurately amplify and identify RNA from the three SARS-CoV-2 variant sequences containing the SGF deletion. By combining the beacons for the wild-type and deletion sequence, we could call wild-type or variant based on the detected sequence, indicating the potential ability for variant calling in the RT-LAMP assay by multiplexed beacon design.

Taken together these data position RT-LAMP as an attractive diagnostic method with a high level of tolerance to common sequence mutations. Recent FDA guidance described a need for understanding this tolerance for any molecular diagnostic test, and use of RT-LAMP could convey increased confidence to developers that a test will maintain performance. In situations where variant identification is desired, the robustness of LAMP primers is a detriment, but use of molecular beacons provides a sensitive addition to specific sequence detection with fluorescence detection. RT-LAMP remains a promising molecular diagnostic method and by further characterizing its behaviors and increasing its applicability we hope to further enable it to bring diagnostic testing to field and point-of-care settings where its advantages can be more fully 

Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2

SARS-CoV-2 (hCoV-19) Mutation Reports (Lineage / Mutation Tracker

Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)

Amplification-refractory mutation system (ARMS) analysis of point mutations

Development of a highly resolved loop-mediated isothermal amplification method to detect the N526K ftsI mutation of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae

FDA. Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests

Mini review: Recent progress in RT-LAMP enabled COVID-19 detection

Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP

Enhancing colorimetric loop-mediated isothermal amplification speed and sensitivity with guanidine chloride

Rapid isothermal amplification and portable detection system for SARS-CoV-2

Development of multiplexed reverse-transcription loopmediated isothermal amplification for detection of SARS-CoV-2 and influenza viral RNA

Detection of SARS-CoV-2 RNA using RT-LAMP and molecular beacons

CRISPR-Cas12-based detection of SARS-CoV-2

Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing

LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding

Diagnosis of SARS-CoV-2 Infection with LamPORE, a High-Throughput Platform Combining Loop-Mediated Isothermal Amplification and Nanopore Sequencing

EMERGENCY USE AUTHORIZATION (EUA) SUMMARY FOR THE COLOR SARS-COV-2 RT-LAMP DIAGNOSTIC ASSAY

Loop-mediated isothermal amplification of DNA

Accelerated reaction by loop-mediated isothermal amplification using loop primers

Establishment of an accurate and fast detection method using molecular beacons in loop-mediated isothermal amplification assay

Locked nucleic acid molecular beacon for multiplex detection of loop mediated isothermal amplification

Molecular Beacons Allow Specific RT-LAMP Detection of B.1.1.7 Variant SARS-CoV-2

SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification

Identification of a Polymorphism in the N Gene of SARS-CoV-2 That Adversely Impacts Detection by Reverse Transcription-PCR

Primer Monitor: an online tool to track SARS-CoV-2 variants that may impact primers used in diagnostic assays

The authors thank Eric Hunt (NEB) for assistance designing the variant primer panels and Nicole Nichols (NEB) for inspiration to conduct the full set of variant profiling experiments. We are grateful to New England Biolabs for funding the work and fostering an environment of scientific discussion and collaboration, without which this work would not have been possible.